/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. The BioHub - by Avetix
  2. Episode 238 - Mandana Honu Fathom Therapeutics
Episode 238 - Mandana Honu Fathom Therapeutics

Episode 238 - Mandana Honu Fathom Therapeutics

The BioHub - by Avetix · Oct 1, 2026

Fathom Therapeutics' CBO Mandana Honu on combining physics and AI to design precise medicines and the critical human element in biotech innovation.

Define Your Biotech's Identity by Its Traits, Not by Admired Competitors

When planning a company's future, founders should avoid naming successful companies as role models. Instead, they should define the specific character traits, values, and impact they want their organization to embody, much like an individual defines their personal goals and character.

Episode 238 - Mandana Honu Fathom Therapeutics thumbnail

Episode 238 - Mandana Honu Fathom Therapeutics

The BioHub - by Avetix·2 months ago

AI Drug Discovery's Real Bottleneck Is a Lack of Novel Lab Instrumentation

The explosion of AI-generated molecular candidates creates a new problem: physically testing them at scale. A significant portion of R&D effort should be redirected from AI model development to inventing novel, high-throughput instrumentation and assays to experimentally validate the flood of predictions AI produces.

Episode 238 - Mandana Honu Fathom Therapeutics thumbnail

Episode 238 - Mandana Honu Fathom Therapeutics

The BioHub - by Avetix·2 months ago

Advanced AI Shifts Human Experts from Building Connections to Analyzing Outcomes

At Fathom Therapeutics, the AI platform autonomously iterates to generate drug candidates, bypassing tedious manual steps. This frees up scientists from the time-consuming "mechanic" work of building molecular connections, allowing them to dedicate their expertise to analyzing the high-quality, system-generated options and data.

Episode 238 - Mandana Honu Fathom Therapeutics thumbnail

Episode 238 - Mandana Honu Fathom Therapeutics

The BioHub - by Avetix·2 months ago

Breakthroughs in AI Drug Discovery Require Humility and Platform Collaboration

No single AI platform can solve the complexities of biology. The greatest impact will come from multiple, specialized platforms—such as generative chemistry, organoids, and virtual cells—working closely together. This requires companies to have humility about their own platform's limitations and prioritize strategic collaboration.

Episode 238 - Mandana Honu Fathom Therapeutics thumbnail

Episode 238 - Mandana Honu Fathom Therapeutics

The BioHub - by Avetix·2 months ago